Schena, E.; Mattioli, E.; Peres, C.; Zanotti, L.; Morselli, P.; Iozzo, P.; Guzzardi, M.A.; Bernardini, C.; Forni, M.; Nesci, S.;
et al. Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction. Cells 2023, 12, 2586.
https://doi.org/10.3390/cells12222586
AMA Style
Schena E, Mattioli E, Peres C, Zanotti L, Morselli P, Iozzo P, Guzzardi MA, Bernardini C, Forni M, Nesci S,
et al. Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction. Cells. 2023; 12(22):2586.
https://doi.org/10.3390/cells12222586
Chicago/Turabian Style
Schena, Elisa, Elisabetta Mattioli, Chiara Peres, Laura Zanotti, Paolo Morselli, Patricia Iozzo, Maria Angela Guzzardi, Chiara Bernardini, Monica Forni, Salvatore Nesci,
and et al. 2023. "Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction" Cells 12, no. 22: 2586.
https://doi.org/10.3390/cells12222586
APA Style
Schena, E., Mattioli, E., Peres, C., Zanotti, L., Morselli, P., Iozzo, P., Guzzardi, M. A., Bernardini, C., Forni, M., Nesci, S., Caprio, M., Cecchetti, C., Pagotto, U., Gabusi, E., Cattini, L., Lisignoli, G., Blalock, W., Gambineri, A., & Lattanzi, G.
(2023). Mineralocorticoid Receptor Antagonism Prevents Type 2 Familial Partial Lipodystrophy Brown Adipocyte Dysfunction. Cells, 12(22), 2586.
https://doi.org/10.3390/cells12222586